ABBV vs BETA · P/E 81, rev $61.16B vs rev $8.9M
AbbVie Inc (ABBV) versus Beta Technologies, Inc. (BETA) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Beta Technologies, Inc. (BETA) is a aerospace & defense company listed on NYSE.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported BETA revenue for 2025-09-30 was $8.9M. Net income was -$437.2M. Revenue was up 190.9% from 2024-09-30 to 2025-09-30. BETA currently screens at market cap $3.72B.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. BETA currently screens at market cap $3.72B.
Not investment advice. Open the ABBV and BETA stock pages for the full models.
Not investment advice.